Adenovirus-mediated inducible nitric oxide synthase gene transfer inhibits hepatocyte apoptosis. 1998

E Tzeng, and T R Billiar, and D L Williams, and J Li, and A Lizonova, and I Kovesdi, and Y M Kim
Department of Surgery, University of Pittsburgh, Pa 15261, USA.

BACKGROUND Apoptosis limits hepatocyte viability in bioartificial livers in vitro and may contribute to liver dysfunction in vivo. Nitric oxide (NO) inhibits hepatocyte apoptosis; however, methods to deliver NO in a sustained manner to hepatocytes are limited. Here, we tested the feasibility of inducible NO synthase (iNOS) gene transfer as an approach to deliver an intracellular source of NO to inhibit spontaneous and tumor necrosis factor-alpha (TNF-alpha)-induced apoptosis in cultured hepatocytes. METHODS An adenoviral vector carrying the human iNOS gene (AdiNOS) was used to overexpress iNOS in cultured rat hepatocytes. Spontaneous apoptosis was induced by prolonged culture (4 days), and stimulated apoptosis was induced by exposure to TNF-alpha + actinomycin D (TNF-alpha ActD). Nitrite (NO2-), cell viability, and cellular caspase-3-like protease activity were measured. RESULTS AdiNOS gene transfer resulted in sustained NO production and protected hepatocytes from spontaneous and TNF-alpha + ActD-induced apoptosis. Apoptosis was associated with increases in caspase-3-like protease activity, which was suppressed by iNOS gene transfer in an NO-dependent manner. Dithiothreitol partially reversed the NO-induced suppression of caspase-3-like activity, which is consistent with S-nitrosylation of caspase-3. CONCLUSIONS Adenovirus-mediated iNOS gene transfer effectively blocks spontaneous and TNF-alpha + ActD-induced cell killing in hepatocytes. iNOS gene transfer could be used to suppress apoptotic hepatocyte death in vitro and possibly in vivo.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D011500 Protein Synthesis Inhibitors Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. Protein Synthesis Antagonist,Protein Synthesis Antagonists,Protein Synthesis Inhibitor,Antagonist, Protein Synthesis,Antagonists, Protein Synthesis,Inhibitor, Protein Synthesis,Inhibitors, Protein Synthesis,Synthesis Antagonist, Protein,Synthesis Inhibitor, Protein
D003546 Cysteine Endopeptidases ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D004229 Dithiothreitol A reagent commonly used in biochemical studies as a protective agent to prevent the oxidation of SH (thiol) groups and for reducing disulphides to dithiols. Cleland Reagent,Cleland's Reagent,Sputolysin,Clelands Reagent,Reagent, Cleland,Reagent, Cleland's
D004792 Enzyme Precursors Physiologically inactive substances that can be converted to active enzymes. Enzyme Precursor,Proenzyme,Proenzymes,Zymogen,Zymogens,Precursor, Enzyme,Precursors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000256 Adenoviridae A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases. Adenoviruses,Ichtadenovirus,Adenovirus,Ichtadenoviruses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

E Tzeng, and T R Billiar, and D L Williams, and J Li, and A Lizonova, and I Kovesdi, and Y M Kim
January 2004, Methods in molecular biology (Clifton, N.J.),
E Tzeng, and T R Billiar, and D L Williams, and J Li, and A Lizonova, and I Kovesdi, and Y M Kim
November 1997, Archives of surgery (Chicago, Ill. : 1960),
E Tzeng, and T R Billiar, and D L Williams, and J Li, and A Lizonova, and I Kovesdi, and Y M Kim
March 2000, Gastroenterology,
E Tzeng, and T R Billiar, and D L Williams, and J Li, and A Lizonova, and I Kovesdi, and Y M Kim
October 2013, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu,
E Tzeng, and T R Billiar, and D L Williams, and J Li, and A Lizonova, and I Kovesdi, and Y M Kim
January 2004, ASAIO journal (American Society for Artificial Internal Organs : 1992),
E Tzeng, and T R Billiar, and D L Williams, and J Li, and A Lizonova, and I Kovesdi, and Y M Kim
May 2003, Molecular therapy : the journal of the American Society of Gene Therapy,
E Tzeng, and T R Billiar, and D L Williams, and J Li, and A Lizonova, and I Kovesdi, and Y M Kim
May 1997, American journal of respiratory cell and molecular biology,
E Tzeng, and T R Billiar, and D L Williams, and J Li, and A Lizonova, and I Kovesdi, and Y M Kim
November 1993, British journal of pharmacology,
E Tzeng, and T R Billiar, and D L Williams, and J Li, and A Lizonova, and I Kovesdi, and Y M Kim
January 2000, The Journal of pharmacology and experimental therapeutics,
E Tzeng, and T R Billiar, and D L Williams, and J Li, and A Lizonova, and I Kovesdi, and Y M Kim
May 2000, Neurosurgery,
Copied contents to your clipboard!